← Back to Search

GUT LINK SmartPath for Gastrointestinal Disorder

N/A

Recruiting

Research Sponsored by Michael Stewart

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 6

Awards & highlights

Study Summary

This trial aims to evaluate a new method called Clinical Care Pathway for diagnosing and treating lower gastrointestinal tract symptoms, like those seen in IBS. Primary healthcare providers often find it difficult to distinguish between

Who is the study for?

This trial is for general practitioners in Nova Scotia, Canada who use 'virtual hallway' for referrals and treat patients with lower GI complaints. It aims to improve the diagnosis and treatment of IBS by implementing a new care pathway.Check my eligibility

What is being tested?

The GUT LINK SmartPath is being tested as a Clinical Care Pathway to help primary healthcare providers better manage lower gastrointestinal tract symptoms and differentiate IBS from more serious conditions.See study design

What are the potential side effects?

Since this study involves the implementation of a care pathway rather than medication, traditional side effects are not applicable. However, there may be challenges or changes in practice management.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 6

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of clicks per referral

Number of referrals

Number of referrals per user

+3 more

Secondary outcome measures

Number of referrals aborted

Number of referrals received requiring troubleshooting

Number referrals received as per prototype

+6 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: GUT LINK SmartPathExperimental Treatment1 Intervention

physicians will use the interactive GUT LINK Smartpath tool in virtual hallway platform to guide their care and referral practices

Group II: controlActive Control1 Intervention

physicians will provide care and refer as per their usual practices

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Michael StewartLead Sponsor

Nova Scotia Health AuthorityOTHER

258 Previous Clinical Trials

83,734 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the primary aim of this research investigation?

"Over a period of 6 months, this study aims to evaluate the number of weekly referrals. Secondary endpoints consist of troubleshooting-requiring referrals, aborted referrals, and consult type classification (Full consult, specialist telephone advice, eConsult)."

Answered by AI

Is the enrollment phase of this medical study currently accepting participants?

"Indeed, information available on clinicaltrials.gov affirms that this investigation is actively pursuing enrollees. The trial was initially uploaded on 2nd January 2024 and the most recent revision occurred on 14th February 2024. The research aims to recruit a total of 120 patients from one designated site."

Answered by AI

How many individuals in total are enrolled in this research project?

"Indeed, the details on clinicaltrials.gov confirm that this research is actively seeking individuals. This study was initially listed on February 1st, 2024, and had its latest update on February 14th, 2024. The trial aims to enroll a total of 120 participants from one location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

GUT LINK: A Study of a Care Pathway Across Primary and GI Specialty Care

Michael Stewart 2024. "GUT LINK: A Study of a Care Pathway Across Primary and GI Specialty Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05725954.

All > Irritable Bowel Syndrome > Ibs